MedPath

Reserch on the effect of losartan on diastolic heart failure patients with hyperuricemia

Not Applicable
Conditions
Elderly diastolic heart failure patients with hyperuricemia
Registration Number
JPRN-UMIN000007846
Lead Sponsor
osartan study group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Medication for high uric acid Creatinine level 2.0mg/dl or over Serum potassium level 5.0meq/l or over Clinical history of Gouty attack Undertreatment of angiotensin receptor blocker NYHA4

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of uric acid level
Secondary Outcome Measures
NameTimeMethod
1.NYHA 2.Rho-kinase activity of circulating leukocyte 3.cyclophilin A, 8-isoproatane 4.pentraxin3, Hs-CRP 5.NT-proBNP 6.renin activity, aldsterone activity 7.echocardiography: ejection fraction, diastolic function(E/A,E/e') 8.flow mediated dilation 9.urinary albumin-to-creatinine ratio 10.Hospitalization for worsenig heart failure,all cause death
© Copyright 2025. All Rights Reserved by MedPath